| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |